As of 4:00pm ET
| +0.09 / +0.23%|
The 1 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 45.00, with a high estimate of 45.00 and a low estimate of 45.00. The median estimate represents a +13.84% increase from the last price of 39.53.
The current consensus among 3 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.